Severely immunodeficient NOD/Shi-scid, IL-2Rγ (NOG) mice provide an in vivo model for human cell/tissue transplantation studies. NOG mice were established by combining interleukin-2 receptor-γ chain knockout mice and NOD/Shi-scid mice. They exhibit a high incidence of thymic lymphomas and immunoglobulin (Ig) leakiness.
View Article and Find Full Text PDFBackground And Objective: Chronic obstructive pulmonary disease (COPD) is considered to be a systemic inflammatory disease, and systemic inflammation has been noted as a factor contributing to cardiovascular disease, which is one of the comorbidities associated with COPD. On the other hand, pleiotropic effects, such as the anti-inflammatory effects of statins, have attracted attention in recent years, and there have been a variety of reports regarding the usefulness of statins for patients with COPD.
Methods: We investigated whether the use or non-use of statins influenced the prevalence of airflow limitation.
Objectives: To test a hypothesis that patients with Parkinson's disease may not notice discrepancies between their perceived and actual stability limits and cannot keep their centre of gravity within the stability region.
Settings: Outpatients with neurological disorders in rehabilitation service.
Subjects: Twenty-one patients with Parkinson's disease (11 men, 10 women; mean duration 5.
Radiolytic one-electron reduction of 1-methylthymine () and 1,3-dimethylthymine () in anoxic aqueous solution afforded stereoisomeric C5-C5'-linked dihydrothymine dimers, fractionated into the meso forms of (5,5)- and (5,5')-bi-5,6-dihydrothymine (,[]) and a racemic mixture of (5,5)- and (5,5)-bi-5,6-dihydrothymines (,[]), along with 5,6-dihydrothymines (,). The meso and racemic dimers were produced in almost equivalent yields, possessing structural similarity with -cyclobutane pyrimidine photodimers that are identified as highly mutagenic and carcinogenic photolesions induced by UV light. Similar radiolytic one-electron reduction of thymidine () resulted in the pseudo-meso form of (5,5)- and (5,5)-bi-5,6-dihydrothymidine ([]) and two diastereormers of (5,5)- and (5,5)-bi-5,6-dihydrothymidine ([] and []).
View Article and Find Full Text PDF